|
National Stock Number(NSN): 6505-01-216-3204 (6505012163204, 012163204)
| NIIN: |
01-216-3204 |
Item Name: |
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE |
INC: |
48876
|
| FSC: |
6505
|
Assignment Date: |
Sep-07-1985 |
CRIT: |
X |
IIG: |
48876 |
| ISC: |
5 |
Date Standardized: |
Sep-07-1985 |
HMIC: |
P |
DODIC: |
|
| NSC: |
0 |
Cancellation Date: |
|
PMIC: |
A |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
3004.90.9270 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
965-10 |
60567
|
LYPHOMED INC DIV OF FUJISAWA USA INC |
C |
5 |
9 |
6 |
54 |
|
B |
|
|
|
|
|
96510 |
60567
|
LYPHOMED INC DIV OF FUJISAWA USA INC |
C |
5 |
9 |
6 |
54 |
|
B |
|
|
|
|
|
NDC00469-0965-10 |
60567
|
LYPHOMED INC DIV OF FUJISAWA USA INC |
C |
3 |
9 |
4 |
ZZ |
|
|
|
|
|
|
|
NDC00469-6510-15 |
60567
|
LYPHOMED INC DIV OF FUJISAWA USA INC |
C |
5 |
9 |
6 |
54 |
|
B |
|
|
|
|
|
56-10 |
60567
|
LYPHOMED INC DIV OF FUJISAWA USA INC |
H |
5 |
9 |
|
|
|
|
|
|
|
|
|
NDC00467-6510-15 |
60567
|
LYPHOMED INC DIV OF FUJISAWA USA INC |
H |
5 |
9 |
|
|
|
|
|
|
|
|
|
NDC00469-5610-30 |
60567
|
LYPHOMED INC DIV OF FUJISAWA USA INC |
H |
5 |
9 |
|
|
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
L |
|
Q |
U |
1 |
A |
$11.75 |
PG |
|
C2201X- |
Jul-01-1995 |
H |
| DF |
S9M |
Y |
|
Q |
U |
1 |
F |
$11.75 |
PG |
|
------- |
Nov-01-1997 |
H |
| DN |
S9M |
Y |
|
Q |
U |
1 |
N |
$11.75 |
PG |
|
9L----- |
Nov-01-1997 |
H |
| DS |
JDC |
L |
|
Q |
U |
1 |
D |
$11.75 |
PG |
|
------- |
Dec-01-1987 |
H |
| VA |
JVS |
I |
|
M |
U |
0 |
V |
$0.00 |
BX |
|
------- |
Sep-01-1985 |
C |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 100EA |
000 |
|
|
|
| DA |
R |
REFER TO NOT DMSB STZD |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 100EA |
000 |
|
|
|
| DF |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 100EA |
000 |
|
|
|
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 100EA |
000 |
|
|
|
| DS |
R |
REFER TO NON-STD NON-DMSB REV |
000 |
|
|
|
| VA |
K |
U/I CONTAINS 25 EA |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
20.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE ACTIVE INGREDIENT |
| CBBL |
FEATURES PROVIDED |
STERILE |
| CQCT |
PRIMARY CONTAINER TYPE |
VIAL, SINGLE DOSE |
| CQGK |
SECONDARY CONTAINER TYPE |
BOX |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
10.000 MILLILITERS |
| CRXL |
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER |
25 VIAL |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
100 |
| CSCX |
TOTAL SECONDARY CONTAINER QUANTITY |
4 |
| CSGS |
ADMINISTRATION |
INTRAVENOUS INFUSION |
| FEAT |
SPECIAL FEATURES |
PRESERVATIVE FREE |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V542 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
Replacement & Obsolete Information
| Replaced / Replacement NIIN Information |
| Obsolete NIIN Information |
|